VENA SEAL CLOSURE SYSTEM VS-402

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2020-02-13 for VENA SEAL CLOSURE SYSTEM VS-402 manufactured by Medtronic Ireland.

Event Text Entries

[179436686] If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[179436687] During procedure, venaseal occluding device was used to treat 7 segments in the great saphenous vein (gsv) in one leg without incident. Patient then received venaseal again and about 4 - 6 weeks after treatment, complained of redness by the access site. Patient was instructed to take medtrol dose pack and contact clinic if symptoms persist. It was discovered that the patient did not take the dose pack nor contacted the office. Patient presented to dermatologist and was placed on antibiotics. The patient has taken the antibiotics prescribed by the dermatologist. Patient is now about 18 months out of treatment date and complaining of slight ulceration and possible e. Coli infection. No further patient injury reported.
Patient Sequence No: 1, Text Type: D, B5


[182473198] Additional information: both left and right legs were treated on the same date. The patient first presented with symptoms 4-6 weeks post procedure. The patient is scheduled for a follow-up visit. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[182473589] Additional information: the patient is reported to be doing much better. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[188633517] Additional information: the physician reported presence of adhesive at the access site resulting in a 2 cm dark lesion, on one of the 2 legs treated. No issues with the other leg. Patient was not seen in the practice for 18 months, so physician assumed the patient was doing fine. She returned to the facility presenting some minor issues at the access site. Patient was seen by a plastic surgeon to see about removing/exploring the site. This has been performed and patient was left with a small scar. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number9612164-2020-00712
MDR Report Key9706326
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2020-02-13
Date of Report2020-03-24
Date of Event2018-04-17
Date Mfgr Received2020-03-13
Device Manufacturer Date2018-02-21
Date Added to Maude2020-02-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactTONI O'DOHERTY
Manufacturer StreetPARKMORE BUSINESS PARK WEST
Manufacturer CityGALWAY
Manufacturer Phone091708734
Manufacturer G1MEDTRONIC IRELAND
Manufacturer StreetPARKMORE BUSINESS PARK WEST
Manufacturer CityGALWAY
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameVENA SEAL CLOSURE SYSTEM
Generic NameAGENT, OCCLUDING, VASCULAR, PERMANENT
Product CodePJQ
Date Received2020-02-13
Catalog NumberVS-402
Lot Number50547
Device Expiration Date2020-02-28
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC IRELAND
Manufacturer AddressPARKMORE BUSINESS PARK WEST GALWAY


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-02-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.